Stifel analyst Rick Wise upgraded Edwards Lifesciences (EW) to Buy from Hold with a price target of $90, up from $75. The firm said that TAVR, ...

The global cardiovascular devices market, valued at US$72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, ...

The Navitor Vision, Abbott's latest TAVI system, is designed to improve accuracy during implantation and enhance visibility ...

TAVIPILOT Soft is said to be a ‘world-first’ provision for real-time surgical guidance during TAVI and TAVR procedures.

Annual Meeting reveals that mechanical aortic valve replacements (AVRs) provide significant long-term survival benefits for ...

We recently compiled a list of the 12 Best Fundamental Stocks to Buy Now. In this article, we are going to take a look at ...

At the Society of Thoracic Surgeons (STS) annual meeting, it was standing room only at a session dedicated to why the ...

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”) ...

A virtual start-up partnered with Nordson MEDICAL for complete design, development, and manufacturing of a catheter-based ...

The scare sent him to see Dr. Kevin Accola, a cardiothoracic surgeon at AdventHealth. Dr. Accola performed a transcutaneous aortic valve replacement, or TAVR procedure. It’s a minimally invasive ...